Home
About
Overview
Sharing Data
ORCID
Help
History (24)
Validation of the RSClin risk calculator in the National Cancer Data Base.
Peptide PHI
Principal Investigator
Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosis.
The host STING pathway at the interface of cancer and immunity.
See All 24 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The host STING pathway at the interface of cancer and immunity.
The host STING pathway at the interface of cancer and immunity. J Clin Invest. 2016 07 01; 126(7):2404-11.
View in:
PubMed
subject areas
Adaptive Immunity
Animals
Antigen-Presenting Cells
Antineoplastic Agents
CD8-Positive T-Lymphocytes
Cytosol
Dendritic Cells
DNA, Neoplasm
Humans
Immunity, Innate
Interferon-beta
Interferons
Mice
Neoplasms
Tumor Microenvironment
authors with profiles
Thomas Gajewski